Sodium Chloride
BACTERIOSTATIC SODIUM CHLORIDE
NADAC/unit
$0.0020
No Shortage
Tier 1: 92.1%
PA Req: 3.0%
9 Manufacturers
28 ANDAs
vs. brand BACTERIOSTATIC SODIUM CHLORIDE: Generic saves up to 100% per unit
Active Shortages
2025-12-03 Discontinuation of the manufacture of the drug, Hospira, Inc., a Pfizer Company
2025-12-03 Discontinuation of the manufacture of the drug, Hospira, Inc., a Pfizer Company
2025-12-03 Discontinuation of the manufacture of the drug, Hospira, Inc., a Pfizer Company
2025-06-10 Discontinuation of the manufacture of the drug, Fresenius Medical Care North America
2025-06-10 Discontinuation of the manufacture of the drug, Fresenius Medical Care North America
Market Intelligence
2025-11-05 Class II Recall: Otsuka ICU Medical LLC
2025-09-10 Class I Recall: B BRAUN MEDICAL INC
2025-08-20 Class II Recall: B BRAUN MEDICAL INC
2025-07-02 Class II Recall: Fresenius Medical Care Holdings, Inc.
2025-07-02 Class II Recall: B BRAUN MEDICAL INC
Generic Manufacturers
B BRAUN MEDICAL INCBAXTER HEALTHCARE CORPFRESENIUS KABI USA LLCFRESENIUS MEDICAL CARE NORTH AMERICAGVS TM INCHIKMA PHARMACEUTICALS USA INCHOSPIRA INCLABORATORIOS GRIFOLS SALIEBEL-FLARSHEIM CO LLCMEDEFIL INCNEPHRON PHARMACEUTICALS CORPORATIONNEXUS PHARMACEUTICALS LLCOTSUKA ICU MEDICAL LLCSPECTRA MEDICAL DEVICES INCTARO PHARMACEUTICALS USA INC
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.